Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study
- PMID: 1574993
- DOI: 10.1111/j.1600-0404.1992.tb04003.x
Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study
Abstract
In this study the regional cerebral glucose utilization and the neuropsychological performance of patients with amyotrophic lateral sclerosis (ALS) was investigated. Special attention was given to neuropsychological tests thought to mirror frontal lobe dysfunction. The regional cerebral glucose utilization was studied in 18 patients using high-resolution positron emission tomography. Clinically all patients displayed upper and lower motor neurone signs. In ALS patients glucose metabolism was significantly reduced in the frontal and in the entire cortex compared with controls; no changes were seen in the cerebellum. Comprehensive neuropsychological assessment of ALS patients compared to a pair matched control group revealed mild frontal dysfunction which in part significantly correlated with reduced glucose metabolism in the cortex and subcortical structures. We conclude that in patients with ALS, glucose consumption is decreased in parts of the brain other than the motor cortex accompanied by mild neuropsychological deficits based on the tests employed in this study.
Similar articles
-
Frontal dysfunctions of ALS-PBP patients in relation to their bulbar symptoms and rCBF decline.J Neurol Sci. 2012 Aug 15;319(1-2):96-101. doi: 10.1016/j.jns.2012.04.020. Epub 2012 May 19. J Neurol Sci. 2012. PMID: 22613760
-
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.Brain. 1996 Dec;119 ( Pt 6):2105-20. doi: 10.1093/brain/119.6.2105. Brain. 1996. PMID: 9010014
-
The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.Brain. 1993 Dec;116 ( Pt 6):1399-423. doi: 10.1093/brain/116.6.1399. Brain. 1993. PMID: 8293278
-
[Frontal type dementia and amyotrophic lateral sclerosis. 3 cases with (HmPAO Tc99m) single-photon emission tomography study].Rev Neurol (Paris). 1995 Nov;151(11):640-7. Rev Neurol (Paris). 1995. PMID: 8745627 Review. French.
-
[Frontal lobe dysfunction in ALS].Srp Arh Celok Lek. 1995 Sep-Oct;123(9-10):266-70. Srp Arh Celok Lek. 1995. PMID: 17974446 Review. Serbian.
Cited by
-
Cognitive function in amyotrophic lateral sclerosis: a cross-sectional and prospective pragmatic clinical study with review of the literature.Neurol Sci. 2023 Dec 18. doi: 10.1007/s10072-023-07262-1. Online ahead of print. Neurol Sci. 2023. PMID: 38105306
-
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.BMJ. 2023 Oct 27;383:e075037. doi: 10.1136/bmj-2023-075037. BMJ. 2023. PMID: 37890889 Free PMC article. Review.
-
Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.Nat Rev Neurol. 2023 Nov;19(11):655-667. doi: 10.1038/s41582-023-00878-z. Epub 2023 Oct 12. Nat Rev Neurol. 2023. PMID: 37828358 Review.
-
Diabetes: a tipping point in neurodegenerative diseases.Trends Mol Med. 2023 Dec;29(12):1029-1044. doi: 10.1016/j.molmed.2023.09.005. Epub 2023 Oct 10. Trends Mol Med. 2023. PMID: 37827904 Review.
-
Nutritional and metabolic factors in amyotrophic lateral sclerosis.Nat Rev Neurol. 2023 Sep;19(9):511-524. doi: 10.1038/s41582-023-00845-8. Epub 2023 Jul 27. Nat Rev Neurol. 2023. PMID: 37500993 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
